Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-17

Clinical Trial Update: Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia [NA]

View source ↗

Summary

This clinical trial update describes an investigation of omega-3 fatty acid supplementation in patients with chronic kidney disease who also have coronary arter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University of Beykent | Conditions: Omega 3 Fatty Acids, Coronary Arterial Disease (CAD) | NA | Status: ACTIVE_NOT_RECRUITING